Greither, T.; Wedler, A.; Rot, S.; Keßler, J.; Kehlen, A.; Holzhausen, H.-J.; Bache, M.; Würl, P.; Taubert, H.; Kappler, M.
CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients. Int. J. Mol. Sci. 2017, 18, 2648.
https://doi.org/10.3390/ijms18122648
AMA Style
Greither T, Wedler A, Rot S, Keßler J, Kehlen A, Holzhausen H-J, Bache M, Würl P, Taubert H, Kappler M.
CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients. International Journal of Molecular Sciences. 2017; 18(12):2648.
https://doi.org/10.3390/ijms18122648
Chicago/Turabian Style
Greither, Thomas, Alice Wedler, Swetlana Rot, Jacqueline Keßler, Astrid Kehlen, Hans-Jürgen Holzhausen, Matthias Bache, Peter Würl, Helge Taubert, and Matthias Kappler.
2017. "CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients" International Journal of Molecular Sciences 18, no. 12: 2648.
https://doi.org/10.3390/ijms18122648
APA Style
Greither, T., Wedler, A., Rot, S., Keßler, J., Kehlen, A., Holzhausen, H.-J., Bache, M., Würl, P., Taubert, H., & Kappler, M.
(2017). CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients. International Journal of Molecular Sciences, 18(12), 2648.
https://doi.org/10.3390/ijms18122648